Kathrin Zitzmann
Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
Zitzmann K, Vlotides G, Brand S, Lahm H, Spöttl G, Göke B, Auernhammer C. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms. Endocr Relat Cancer 2012; 19:423-34.
24.05.2012Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
24.05.2012Endocr Relat Cancer 2012; 19:423-34
Zitzmann Kathrin, Vlotides George, Brand Stephan, Lahm Harald, Spöttl Gerald, Göke Burkhard, Auernhammer Christoph J
The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells
Zitzmann K, de Toni E, von Rüden J, Brand S, Göke B, Laubender R, Auernhammer C. The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells. Endocr Relat Cancer 2011; 18:277-85.
21.03.2011The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells
21.03.2011Endocr Relat Cancer 2011; 18:277-85
Zitzmann Kathrin, de Toni Enrico, von Rüden Janina, Brand Stephan, Göke Burkhard, Laubender Rüdiger P, Auernhammer Christoph J
Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus
Diegelmann J, Beigel F, Zitzmann K, Kaul A, Göke B, Auernhammer C, Bartenschlager R, Diepolder H, Brand S. Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PloS one 2010; 5:e15200.
08.12.2010Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus
08.12.2010PloS one 2010; 5:e15200
Diegelmann Julia, Beigel Florian, Zitzmann Kathrin, Kaul Artur, Göke Burkhard, Auernhammer Christoph J, Bartenschlager Ralf, Diepolder Helmut M, Brand Stephan
Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease
Zitzmann K, Rüden J, Brand S, Göke B, Lichtl J, Spöttl G, Auernhammer C. Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease. Cancer Lett 2010; 295:100-9.
30.03.2010Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease
30.03.2010Cancer Lett 2010; 295:100-9
Zitzmann Kathrin, Rüden Janina von, Brand Stephan, Göke Burkhard, Lichtl Jennifer, Spöttl Gerald, Auernhammer Christoph J
The role of interleukin-22 in hepatitis C virus infection
Dambacher J, Beigel F, Zitzmann K, Heeg M, Göke B, Diepolder H, Auernhammer C, Brand S. The role of interleukin-22 in hepatitis C virus infection. Cytokine 2008; 41:209-16.
11.01.2008The role of interleukin-22 in hepatitis C virus infection
11.01.2008Cytokine 2008; 41:209-16
Dambacher Julia, Beigel Florian, Zitzmann Kathrin, Heeg Malte H J, Göke Burkhard, Diepolder Helmut M, Auernhammer Christoph J, Brand Stephan
SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells
Zitzmann K, Brand S, De Toni E, Baehs S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. Cancer Res 2007; 67:5025-32.
15.05.2007SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells
15.05.2007Cancer Res 2007; 67:5025-32
Zitzmann Kathrin, Brand Stephan, De Toni Enrico N, Baehs Sebastian, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich H H D, Auernhammer Christoph J
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells
Zitzmann K, De Toni E, Brand S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells. Neuroendocrinology 2007; 85:54-60.
19.02.2007The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells
19.02.2007Neuroendocrinology 2007; 85:54-60
Zitzmann Kathrin, De Toni Enrico N, Brand Stephan, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich H D, Auernhammer Christoph J
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
Brand S, Thasler W, Bilzer M, Diepolder H, Göke B, Storr M, Steib C, Olszak T, Prüfer T, Weiss T, Heeg M, Zitzmann K, Beigel F, Dambacher J, Auernhammer C. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1019-28.
04.01.2007IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
04.01.2007Am J Physiol Gastrointest Liver Physiol 2007; 292:G1019-28
Brand Stephan, Thasler Wolfgang E, Bilzer Manfred, Diepolder Helmut, Göke Burkhard, Storr Martin, Steib Christian J, Olszak Torsten, Prüfer Thomas, Weiss Thomas S, Heeg Malte H J, Zitzmann Kathrin, Beigel Florian, Dambacher Julia, Auernhammer Christoph J
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells
Zitzmann K, Brand S, Baehs S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells. Biochem Biophys Res Commun 2006; 344:1334-41.
24.04.2006Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells
24.04.2006Biochem Biophys Res Commun 2006; 344:1334-41
Zitzmann Kathrin, Brand Stephan, Baehs Sebastian, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich, Auernhammer Christoph J
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
Brand S, Auernhammer C, Göke B, Ochsenkühn T, Seiderer J, Herrmann K, Leclair S, Popp A, Jagla W, Marquardt A, Diepolder H, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-38.
01.04.2006IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
01.04.2006Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-38
Brand Stephan, Auernhammer Christoph J, Göke Burkhard, Ochsenkühn Thomas, Seiderer Julia, Herrmann Karin, Leclair Stéphane, Popp Andreas, Jagla Wolfgang, Marquardt Andreas, Diepolder Helmut, Otte Jan-Michel, Eichhorst Sören T, Zitzmann Kathrin, Olszak Torsten, Beigel Florian, Dambacher Julia
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
Brand S, Göke B, Auernhammer C, Adler B, Diepolder H, Diebold J, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005; 289:G960-8.
28.07.2005IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
28.07.2005Am J Physiol Gastrointest Liver Physiol 2005; 289:G960-8
Brand Stephan, Göke Burkhard, Auernhammer Christoph J, Adler Barbara, Diepolder Helmut, Diebold Joachim, Otte Jan-Michel, Eichhorst Sören T, Zitzmann Kathrin, Olszak Torsten, Beigel Florian, Dambacher Julia
SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29
Brand S, Diepolder H, Göke B, Eichhorst S, Vlotides G, Olszak T, Beigel F, Dambacher J, Zitzmann K, Auernhammer C. SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Biochem Biophys Res Commun 2005; 331:543-8.
03.06.2005SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29
03.06.2005Biochem Biophys Res Commun 2005; 331:543-8
Brand Stephan, Diepolder Helmut, Göke Burkhard, Eichhorst Sören T, Vlotides George, Olszak Torsten, Beigel Florian, Dambacher Julia, Zitzmann Kathrin, Auernhammer Christoph J
SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA
Vlotides G, Sörensen A, Kopp F, Zitzmann K, Cengic N, Brand S, Zachoval R, Auernhammer C. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun 2004; 320:1007-14.
30.07.2004SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA
30.07.2004Biochem Biophys Res Commun 2004; 320:1007-14
Vlotides George, Sörensen Astrid S, Kopp Florian, Zitzmann Kathrin, Cengic Neziha, Brand Stephan, Zachoval Reinhart, Auernhammer Christoph J